Infliximab belongs to a class of medicines called biological disease modifying antirheumatic drugs (biological DMARDs or bDMARDs).
Tocilizumab (brand name Actemra) belongs to a class of medicines called biological disease modifying antirheumatic drug
Certolizumab (brand name Cimzia) belongs to a lass of medicines called biological disease modifying antirheumatic drugs
Etanercept (brand name Enbrel) is one of a group of medicines called biological disease modifying antirheumatic drugs.
Adalimumab belongs to a class of medicines called biological disease modifying antirheumatic drugs (biological DMARDs or or bDMARDs)
Rituximab (brand name Mabthera, Mabthera SC, Riximyo, Truxima)) belongs to a new class of medicines called biological disease-modifying...
Abatacept (brand name Orencia) belongs to a new class of medicines called biological disease modifying antirheumatic drugs (biological DMARD
Golimumab belongs to a class of medicines called biological disease modifying antirheumatic drugs (biological DMARDs or bDMARDs).
Biologics are a type of medication that can be prescribed for some forms of inflammatory arthritis ...
They are a type of medication called a disease-modifying anti-rheumatic drug or DMARD for short ...
Upadacitinib is a medicine used to treat symptoms of rheumatoid arthritis.
This website has been independently developed by Arthritis Australia for Australian users. We thank our sponsors for their support for an unrestricted, educational grant to fund its creation.